Jay Fuletra

Jay Fuletra practices at The Bryn Mawr Urology Group in Rosemont, Pennsylvania.

Jay Fuletra's NPI, 1295268878, was assigned on April 10, 2017. Jay Fuletra holds Pennsylvania license MD469411.

Jay Fuletra's primary practice is The Bryn Mawr Urology Group, at 919 Conestoga Road, Rosemont, PA 19010. The practice phone is (610) 525-6580. Jay Fuletra also practices at Academic Urology of PA, LLC, 2 Industrial Blvd, Paoli, PA 19301.

Jay Fuletra's primary practice is The Bryn Mawr Urology Group in Rosemont, Pennsylvania. Jay Fuletra is also affiliated with Lankenau Medical Center. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Jay Fuletra to 2 more hospitals, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jay Fuletra practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Jay Fuletra's primary specialty in the NPI Registry, under taxonomy code 208800000X. Jay Fuletra is licensed in Pennsylvania.

CMS data shows 2,776 Medicare services from Jay Fuletra across 24 procedure codes in 2024, for 537 Medicare patients. Medicare paid $143,724 for them.

CMS counts 537 Medicare patients who saw Jay Fuletra in 2024. The largest group is 65 to 74, with 253 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Jay Fuletra's median patient age at 69, with 19% women.

In 2024, Jay Fuletra wrote 885 Medicare Part D claims for 327 patients. 88% of them were for generic drugs. CMS names the drug for 787 of them, across 16 drugs with 11 or more claims each, at $119,706 in total drug cost. In 2023, CMS named 104 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Jay Fuletra for performance year 2024, reported as part of a group. Jay Fuletra accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 16 procedures of prostate resection by Jay Fuletra, more than 74% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Jay Fuletra, published from 2014 to 2023. 2022 was the busiest year, with 2. The most frequent topics are Prostatic Neoplasms. Jay Fuletra's most frequent co-authors are Ahmad Alzubaidi, MD, Matthew G. Kaag, MD and Suzanne Biehn Merrill, MD.

CMS Open Payments shows 126 general payments to Jay Fuletra from 30 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 68% of the total. Intuitive Surgical, Inc. paid the most, $1,556.